Independent (Predictor) Variable | Survivors (N/%) | Non-survivors (N/%) | Univariate analysis | Multivariate analysis | Â | Â | Â | Â |
---|---|---|---|---|---|---|---|---|
 |  |  | O.R. | 95% C.I. | P-value | O.R. | 95% C.I. | P-value |
Age | Â | Â | Â | Â | Â | Â | Â | Â |
≤ 40 | 77(79.4) | 22(22.6) |  |  |  |  |  |  |
> 40 | 5 (71.4) | 2(28.6) | 1.23 | 0.24-2.98 | 0.984 | 2.32 | 0.43-2.45 | NS |
Sex | Â | Â | Â | Â | Â | Â | Â | Â |
Male | 58 (77.3) | 17(22.7) | Â | Â | Â | Â | Â | Â |
Female | 22 (75.9) | 7 (24.1) | 2.21 | 0.95-2.76 | 0.051 | 1.32 | 0.22-2.32 | NS |
Duration of illness | Â | Â | Â | Â | Â | Â | Â | Â |
Within 14 days | 64 (76.2) | 20 (23.8) | Â | Â | Â | Â | Â | Â |
After 14 days | 16 (80.0) | 4 (20.0) | 1.11 | 0.57-1.98 | 0.454 | 1.67 | 0.78-2.11 | NS |
Perforation-admission interval | Â | Â | Â | Â | Â | Â | Â | Â |
Within 24 hours | 15 (93.7) | 1 (6.3) | Â | Â | Â | Â | Â | Â |
After 24 hours | 65 (73.7) | 23 (26.1) | 2.43 | 1.34-3.54 | 0.024 | 1.67 | 1.12-3.43 | 0.003 |
Timing of operation | Â | Â | Â | Â | Â | Â | Â | Â |
Within 24 hours | 12(85.7) | 2(14.3) | Â | Â | Â | Â | Â | Â |
After 24 hours | 68 (75.6) | 22(24.4) | 0.21 | 0.11-0.98 | 0.011 | 1.23 | 1.12-3.65 | 0.034 |
HIV status | Â | Â | Â | Â | Â | Â | Â | Â |
Positive | 3 (33.3) | 6(66.7) | Â | Â | Â | Â | Â | Â |
Negative | 63 (79.7) | 16 (20.3) | Â | Â | Â | Â | Â | Â |
Not known | 14 (87.5) | 2 (12.5) | 3.54 | 2.46-4.98 | 0.031 | 0.23 | 0.11-0.98 | 0.022 |
CD4+ count (cells/μl) |  |  |  |  |  |  |  |  |
≤ 200 | 1(33.3) | 2 (66.7) |  |  |  |  |  |  |
> 200 | 3(75.0) | 1(25.0) | 5.34 | 3.45-6.98 | 0.004 | 4.54 | 3.23-6.87 | 0.000 |
Prehospital antibiotic therapy | Â | Â | Â | Â | Â | Â | Â | Â |
Adequate | 23 (88.5) | 3 (11.5) | Â | Â | Â | Â | Â | Â |
Inadequate | 52 (72.2) | 20 (27.8) | Â | Â | Â | Â | Â | Â |
Not documented | 7 (87.5) | 1 (12.5) | 2.87 | 2.11-4.50 | 0.021 | 3.11 | 1.45-7.86 | 0.006 |
ASA classes | Â | Â | Â | Â | Â | Â | Â | Â |
I-II (Low risk group) | 26 (92.9) | 2 (7.1) | Â | Â | Â | Â | Â | Â |
III-V (High risk group) | 54 (71.1) | 22 (28.9) | 0.32 | 0.11-0.98 | 0.033 | 3.2 | 2.34-6.81 | 0.012 |
SBP on admission | Â | Â | Â | Â | Â | Â | Â | Â |
≤ 90 mmHg | 22 (61.1) | 14 (38.9) |  |  |  |  |  |  |
> 90 mmHg | 58(85.3) | 10 (14.7) | 3.45 | 1.56-4.91 | 0.011 | 1.98 | 1.72-4.98 | 0.000 |
Type of peritonitis | Â | Â | Â | Â | Â | Â | Â | Â |
Generalized | 74(77.1) | 22 (22.9) | Â | Â | Â | Â | Â | Â |
Localized | 6(75.0) | 2(25.0) | 1.95 | 0.98-2.75 | 0.967 | 0.32 | 0.11-1.63 | NS |
Amount of peritoneal fluid/pus | Â | Â | Â | Â | Â | Â | Â | Â |
≤ 1000 mls | 13 (86.7) | 2 (13.3) |  |  |  |  |  |  |
> 1000 ml | 67(75.3) | 22 (24.7) | 1.52 | 1.18-2.22 | 0.023 | 1.22 | 1.09-1.76 | 0.011 |
Number of perforations | Â | Â | Â | Â | Â | Â | Â | Â |
Single | 71 (80.7) | 17 (19.3) | Â | Â | Â | Â | Â | Â |
Multiple | 9 (56.2) | 7(43.8) | 1.54 | 1.11-4.87 | 0.012 | 2.89 | 2.33-5.98 | 0.007 |
Postoperative complications | Â | Â | Â | Â | Â | Â | Â | Â |
Present | 25 (61.0) | 16 (39.0) | Â | Â | Â | Â | Â | Â |
Absent | 55 (87.3) | 8 (12.7) | 2.98 | 2.33-4.91 | 0.004 | 5.22 | 3.43-6.94 | 0.000 |